Accustem Sciences Inc. (ACUT)

Accustem Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020
Cost of Revenue	0	0	0	0
Gross Profit	-0	-0	0	0
Selling, General & Admin	1.91	3.48	0.6	0.05
Research & Development	0.14	0.27	0.07	0.01
Operating Expenses	2.05	3.74	0.67	0.05
Operating Income	-2.05	-3.75	-0.67	-0.05
Other Expense / Income	0	-	0	0
Pretax Income	-2.05	-3.75	-0.67	-0.05
Income Tax	-0	-0	-0	-0
Net Income	-2.05	-3.75	-0.67	-0.05
Shares Outstanding (Basic)	11	11	11	11
Shares Outstanding (Diluted)	11	11	11	11
Shares Change	3.00%	-2.83%	-	-
EPS (Basic)	-0.18	-0.34	-0.06	-0.00
EPS (Diluted)	-0.18	-0.34	-0.06	-0.00
Free Cash Flow	-1.62	-1.82	-0.39	0
Free Cash Flow Per Share	-0.14	-0.16	-0.03	0.00
EBITDA	-2.05	-3.74	-0.67	-0.05
Depreciation & Amortization	0	0	0	0
EBIT	-2.05	-3.75	-	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.